Literature DB >> 9347849

Abdominal operations in patients with cirrhosis: still a major surgical challenge.

A Mansour1, W Watson, V Shayani, J Pickleman.   

Abstract

BACKGROUND: Hepatic transplantation and portasystemic shunts can be safely performed in patients with advanced liver disease, whereas other abdominal procedures appear to have a much higher mortality rate. This study reviews the outcomes of patients with cirrhosis after the full spectrum of abdominal operations.
METHODS: In a 12-year period, 92 patients diagnosed with cirrhosis required either an emergent or elective abdominal operation. There were four categories of operations: cholecystectomy in 17 patients, hernia in 9, gastrointestinal tract in 54, and other procedures in 12. Fifty-five clinical, laboratory, and operative variables were analyzed to identify factors predictive of poor outcome.
RESULTS: Coagulopathy developed in 24 patients (27%) and sepsis in 15 (16%). The mortality rate after emergent operations was 50%, compared to 18% for elective cases (p = 0.001). Other factors that predicted mortality included the presence of ascites (p = 0.006), encephalopathy (p = 0.002), and elevated prothrombin time (p = 0.021). The mortality in Child's class A patients was 10%, compared to 30% in class B and 82% in class C patients.
CONCLUSIONS: Patients with cirrhosis undergoing elective or emergent operations are at a significant risk of developing postoperative complications leading to death. The most accurate predictor of outcome is the patient's preoperative Child's class.

Entities:  

Mesh:

Year:  1997        PMID: 9347849     DOI: 10.1016/s0039-6060(97)90080-5

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  88 in total

1.  Traumatic splenectomy in a cirrhotic patient with hepatitis C and alcoholic liver disease.

Authors:  Hosam E Matar; Ashraf S Elmetwally; Manojkumar S Nair; Rudi Borgstein; Olu Oluwajobi
Journal:  BMJ Case Rep       Date:  2012-01-03

2.  Preoperative evaluation and risk management.

Authors:  David P Parsons
Journal:  Clin Colon Rectal Surg       Date:  2009-02

3.  Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy.

Authors:  Andrea Belli; Luigi Cioffi; Gianluca Russo; Giulio Belli
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

4.  Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation.

Authors:  Roshan Shrestha; David M S Grunkemeier
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

5.  Major abdominal cancer resections in cirrhotic patients: how frequent is postoperative hepatocellular decompensation?

Authors:  Shailesh Vinayak Shrikhande; Vinay Gaikwad; Dipak Purohit; Mahesh Goel
Journal:  Indian J Gastroenterol       Date:  2013-11-12

Review 6.  Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions.

Authors:  Kira L Newman; Kay M Johnson; Paul B Cornia; Peter Wu; Kamal Itani; George N Ioannou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-31       Impact factor: 11.382

7.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 8.  Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Zenichi Morise
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-16

9.  Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.

Authors:  Beatriz P Costa; F Castro Sousa; Marco Serôdio; César Carvalho
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

10.  Predictors of negative intraoperative findings at emergent laparotomy in patients with cirrhosis.

Authors:  Elliot B Tapper; Vilas Patwardhan; Laura M Mazer; Byron Vaughn; Gail Piatkowski; Amy R Evenson; Raza Malik
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.